CNBX · CNBX Pharmaceuticals Inc. · Documents
$0.00
+0.00 (+0.00%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jun 24, 2026
Substantial doubt about the company's ability to continue as a going concern.
“While the Company has incurred a net loss of $311,982 for the nine months ended May 31, 2026, it has incurred cumulative losses since inception of $25,580,358. These conditions raise substantial doubt about the ability of the Company to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon its abilities to generate revenues, to continue to raise investment capital, and develop and implement its business plan. No assurance can be given that the Company will be successful in these efforts.”View the 10-Q filed Jun 24, 2026
Market Cap
$160,576
Shares
1.61B
Volume · Oct 22
70.04M
Avg daily vol (3M)
5.6M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.